Abstract:INTRODUCTION & HYPOTHESIS: Heart disease is the leading cause of death in developed nations and remains a significant public health problem both in the United States and globally. Human embryonic stem cell therapy demonstrates to be an effective means of treating ischemic heart diseases, as it possesses the capability of generating de novo tissue populations. To investigate such populations’ in vivo and in vitro behavioral characteristics as well as clinical potentials, molecular imaging proves to be a vital tool. However, thus far, genetic integration mainly relies upon the unsafe, unstable, and untranslatable method of random integration. We hypothesized that to address such barrier, we can utilize novel zinc finger nuclease (ZFN) technology to integrate reporter genes into human pluripotent stem cells for cardiac cell derivation, delivery, and molecular imaging. METHODS & RESULTS: Using ZFN technology, we integrated a triple fusion gene construct of mRFP-Fluc-HSVtk into the safe AAVS1 locus for fluorescence, bioluminescence, and positron emission tomography imaging. No discernible off-target cleavages or random integration was detected, and we achieved a high efficiency of ZFN-mediated targeted integration. We observed long-term reporter gene expression as well as pluripotency conservation; the cells retained both expression of pluripotency markers - Oct4, Tra-1-60, Sox2, Tra-1-81, Nanog and SSEA4 - as wells as ability to differentiate into 3 germ layers via in vivo teratoma formation and in vitro embryoid body formation. We then differentiated the ZFN-modified ESCs into cardiomyocytes and endothelial cells in vitro . Parallel characterization of differentiation efficiency and cardiac marker expression of ZFN-modified ESCs and blank ESCs showed no significant differences between the two. Functionally, we tracked the survival of ZFN-edited pluripotent cells in murine models, demonstrating the cardiovascular applicability of ZFN-edited cells. CONCLUSION: This study demonstrates the great potentials and applicability of ZFN transgenesis technology use in safe, stable, and effective genetic integration for the molecular imaging of human pluripotent stem cells and beyond.

Fluorescent indicators for continuous and lineage‐specific reporting of cell‐cycle phases in human pluripotent stem cells

Human induced pluripotent stem cells for live cell cycle monitoring and endogenous gene activation

Establishment of drug screening in human embryonic stem cells based on a high-content screening system.

Genome Editing of Human Embryonic Stem Cells and Induced Pluripotent Stem Cells with Zinc Finger Nucleases for Cellular Imaging.

Gene Editing to Generate Versatile Human Pluripotent Stem Cell Reporter Lines for Analysis of Differentiation and Lineage Tracing

Developing CRISPR/Cas9-Mediated Fluorescent Reporter Human Pluripotent Stem-Cell Lines for High-Content Screening

CRISPR/Cas9-mediated knock-in of a fluorescent reporter into the target locus of interest in human pluripotent stem cells

Fucci-guided purification of hematopoietic stem cells with high repopulating activity

Visualization of cell cycle in mouse embryos with Fucci2 reporter directed by Rosa26 promoter

Fucci2a: a bicistronic cell cycle reporter that allows Cre mediated tissue specific expression in mice

Fluorescent Indicators for Simultaneous Reporting of All Four Cell Cycle Phases.

Mapping human pluripotent stem cell differentiation pathways using high throughput single-cell RNA-sequencing.

Engineering fluorescent reporters in human pluripotent cells and strategies for live imaging human neurogenesis

Simultaneous quantitative assessment of two distinct cell lineages with a nuclear-localized dual genetic reporter

Fluorescent hiPSC-derived MYH6-mScarlet cardiomyocytes for real-time tracking, imaging, and cardiotoxicity assays

Tissue-specific promoter-based reporter system for monitoring cell differentiation from iPSCs to cardiomyocytes

Generation of green fluorescent protein reporter knock-in iPSC line at the 3'UTR region of the KLOTHO locus

Abstract 9374: Zinc Finger Nuclease Technology for Human Pluripotent Stem Cell Genomic Modification and in Vivo Tracking

A highly efficient reporter system for identifying and characterizing in vitro expanded hematopoietic stem cells

Generation of a CAG-EGFP tagged cell line (KSCBi017-A-2) from human induced pluripotent stem cells using CRISPR/Cas9

Transgenic systems for unequivocal identification of cardiac myocyte nuclei and analysis of cardiomyocyte cell cycle status